πŸ‡ΊπŸ‡Έ FDA
Patent

US 9822184

DCLK1 short form specific binding agents

granted A61KA61K39/00

Quick answer

US patent 9822184 (DCLK1 short form specific binding agents) held by The Board of Regents of the University of Texas System expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K39/00